Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT01772212
Status:
COMPLETED
Last Update Posted:
2017-06-22
First Post:
2013-01-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioequivalence Study for Terbinafine 250 mg
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2011-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-17
First Submit QC Date:
None
Study First Post Date:
2013-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-21
Last Update Post Date:
2017-06-22
Last Update Post Date Type:
ACTUAL